Alaproclate
A selective serotonin reuptake inhibitor
Alaproclate | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Alaproclate is a pharmacological compound that functions as a selective serotonin reuptake inhibitor (SSRI). It was primarily researched for its potential use as an antidepressant but is not currently marketed for clinical use.
Mechanism of Action[edit | edit source]
Alaproclate acts by inhibiting the reuptake of serotonin (5-HT) into the presynaptic neuron, thereby increasing the availability of serotonin in the synaptic cleft. This mechanism is similar to that of other SSRIs, which are commonly used in the treatment of depression and anxiety disorders.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of alaproclate includes its absorption, distribution, metabolism, and excretion. Alaproclate is administered orally and is absorbed through the gastrointestinal tract. It is metabolized in the liver and excreted primarily through the kidneys.
Synthesis[edit | edit source]
The synthesis of alaproclate involves several chemical reactions, starting from basic organic compounds. The process is depicted in the image below:
Clinical Research[edit | edit source]
Alaproclate was studied in clinical trials to evaluate its efficacy and safety as an antidepressant. However, it did not progress to become a marketed drug. The reasons for this could include insufficient efficacy, adverse effects, or the development of more effective alternatives.
Side Effects[edit | edit source]
As with other SSRIs, alaproclate may cause side effects such as nausea, headache, dizziness, and insomnia. The side effect profile is an important consideration in the development and approval of new pharmacological agents.
Related Compounds[edit | edit source]
Alaproclate is related to other SSRIs such as fluoxetine, sertraline, and citalopram. These compounds share a similar mechanism of action but may differ in their pharmacokinetic properties and side effect profiles.
Related pages[edit | edit source]
Gallery[edit | edit source]
Alaproclate[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD